Posttraumatic stress disorder with and without consequent addiction disorders: Putative differentiating role of the HPA-system

Recruiting

• Conditions: F11; Other reactions to severe stress; F43.1; F10; F12; F15; Post-traumatic stress disorder; Mental and behavioural disorders due to use of opioids; F43.8; F14

• Registration Number: DRKS00010118
• Lead Sponsor: Fachklinik St. Marienstift Dammer Berge

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2016-08-08
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 400

Inclusion Criteria

ICD-10 Diagnosis PTBS
- Additional addiction diagnosis according to ICD-10 or no additional addiction diagnosis according to ICD-10
- Sufficient understanding of language to fill in the questionnaires in German or with a interpreter via the mother tongue
- Completed detoxification

Exclusion Criteria

- Additional ICD-10 diagnosis of Schizophrenia
- Additional ICD-10 diagnosis of intelligence impairment
- Additional ICD-10 diagnosis of dementia
- Physical impairment/disease that renders study participation unlikely
- grave anemia, hb below 9 mg/dl, erythrozyten below 3/pl in peripheral blood

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The end of participation will be reached if participants complete the following study parts: Taking of the blood sample, anamnesis and completion of all questionnaires and psychological tests. Collection of data will take approximately 8 weeks (due to the variable schedule of taking the blood sample), at a maximum the duration of the therapy. Primary outcome is the blood sample to identify the genetic material in the stress hormone system.